← Back to Search

Placebo

Blepharoptosis Repair for Drooping Eyelid

N/A
Recruiting
Led By Matthew Lee-Wing, MD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must have bilateral blepharoptosis undergoing repair using an anterior approach
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 years
Awards & highlights

Study Summary

This trial is testing whether injecting local anesthetic through the back of the eyelid reduces pain during a common surgical procedure to fix droopy eyelids.

Eligible Conditions
  • Drooping Eyelid
  • Droopy Eyelid

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You need surgery for droopy eyelids on both eyes, and the surgeon will use an approach that starts from the front of the eyelids.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
0-10 Numerical Pain Scale
Secondary outcome measures
Post-Operative margin-reflex distance 1
Presence of post-operative lagophthalmos/fluorescein staining

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Subcut. + Subconj. InjectionExperimental Treatment2 Interventions
Patients will undergo standard blepharoptosis repair using an anterior approach, with an added injection of local anesthetic (Xylocaine) beneath the conjunctiva of the lid being operated on. They will still receive the standard subcutaneous local anesthetic given during blepharoptosis repair.
Group II: Subcut. + Sham Subconj. InjectionPlacebo Group2 Interventions
Patients will undergo standard blepharoptosis repair using an anterior approach, however they will not receive the additional subconjunctival Xylocaine injection. Instead, they will receive a sham injection of Normal Saline to prevent them from knowing which eye received the additional anesthetic.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,422 Total Patients Enrolled
Matthew Lee-Wing, MDPrincipal InvestigatorUniversity of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you elaborate on the past experiments involving Blepharoptosis Repair?

"Presently, 118 medical studies are researching the repair of Blepharoptosis and 31 trials have reached Phase 3. Not to mention, there exists a plethora of clinical trial locations for this condition - 1094 in total - with many based out of Calgary, Alberta."

Answered by AI

What medical issue is Blepharoptosis Repair commonly used to address?

"Blepharoptosis Repair is typically utilized to address cervical syndrome. Though, it also has a role in the treatment of minor burns, transplantation complications and osteoporosis."

Answered by AI

Is it still possible to apply for participation in this experiment?

"Affirmative. According to clinicaltrials.gov, this research is recruiting participants at present. The study was originally posted on September 1st 2017 and the most recent update occurred June 7th 2022. 100 individuals need to be enrolled between 2 separate locations."

Answered by AI

How many individuals are being enrolled in this clinical trial?

"Affirmative. The information hosted on clinicaltrials.gov affirms that this medical trial, first posted September 1st 2017, is recruiting participants at present. There are two sites in total and the research team needs to find 100 patients altogether."

Answered by AI
~13 spots leftby Apr 2025